Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2095443 | 0.76 | ALDH1A1 (0.43) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL54889 | 0.76 | LMNA (0.47) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL28184037 | 0.73 | ALDH1A1 (0.40) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL29068856 | 0.73 | MRGPRX4 (0.41) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL19983998 | 0.73 | ALDH1A1 (0.42) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL19979064 | 0.73 | ALDH1A1 (0.39) | MEN1ALDH1A1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL5368610 | 0.72 | CYP1A2 (0.45) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL19979063 | 0.69 | ALDH1A1 (0.35) | MEN1ALDH1A1KMT2ALMNACXCL8 | |
| SCHEMBL8667994 | 0.69 | ALDH1A1 (0.48) | MEN1ALDH1A1KMT2ATDP1LMNA | |
| SCHEMBL1982757 | 0.68 | TLR8 (0.45) | MEN1ALDH1A1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10618872-B2 | Process for preparing 3-chloro-2-vinylphenylsulfonates | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-04-14 | — | — | US | disclosed |
| EP-3265439-B1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | BAYER CROPSCIENCE AG (DE) | 2019-03-27 | — | — | EP | disclosed |
| US-20180079717-A1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079717-A1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | AGPS, VARS1, VPS4B | MEN1 3202/4885ALDH1A1 3434/4885KMT2A 2164/4885 |
| US-10618872-B2 | Process for preparing 3-chloro-2-vinylphenylsulfonates | AGPS, VARS1, VPS4B | MEN1 3202/4885ALDH1A1 3434/4885KMT2A 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.